$NTHI News

BTIG Reiterates Buy on NeOnc Technologies Hldgs, Maintains $15 Price Target

Alliance Global Partners Initiates Coverage On NeOnc Technologies Hldgs with Buy Rating, Announces Price Target of $13

Maxim Group Initiates Coverage On NeOnc Technologies Hldgs with Buy Rating, Announces Price Target of $20

NeOnc Technologies Q1 EPS $(0.38) Misses $(0.17) Estimate

NeOnc Technologies Says CEO, Executive Chairman, And President Amir Heshmatpour Increases Personal Ownership Through Consistent Open-Market Purchases

BTIG Initiates Coverage On NeOnc Technologies Hldgs with Buy Rating, Announces Price Target of $15

NeOnc Technologies Announces That Chairman And CEO Amir Heshmatpour Purchased $300K Worth Of Company Shares Last Week

NeOnc Technologies Announces That Chairman And CEO Amir Heshmatpour Purchased $300K Worth Of Company Shares Last Week

NeOnc Technologies Holdings Enters Equity Distribution Agreement To Sell Up To $75M Of Common Stock Via Atm Program

NeOnc Technologies Files Prospectus To Offer Up To $300M In Common Stock, Preferred Stock, Debt, And Other Securities

NeOnc Provides Business Update and Reports Q4 2025 Financial Results

NeOnc Technologies Q4 EPS $(0.72) Misses $(0.37) Estimate

NeOnc Technologies Appoints David Choi as Chief Accounting Officer

Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)

NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET

NeOnc Technologies Announces Data From Dose-Escalation Portion Of Phase 1/2 Clinical Trial For NEO212, Oral Bio-Conjugated Therapy

NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity

NeOnc To Host Investor Conference Call To Present Initial Data From Phase 1 Dose-Escalation Portion Of NEO212-01 Phase 1/2 Clinical Trial, Evaluating TMZ Platform In Oral Formulation For Patients With CNS Malignancies

New to The Street(R) Airs Tonight on Bloomberg Television Across the U.S., MENA & Latin America

NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management